a method for administering an ocular analgesic is described . the method includes the steps of providing a topical analgesic that includes a neo - tryptophan - containing neurotensin analog and applying the topical analgesic to the ocular tissue in a dose of about 0 . 0001 to about 5 mg alternatively about 0 . 0001 to about 3 mg , alternatively about 0 . 0005 to about 1 . 2 mg , alternatively about 0 . 0005 to about 1 . 0 mg , alternatively about 0 . 00075 to about 1 . 0 mg , alternatively about 0 . 001 mg to about 1 . 0 mg , alternatively about 0 . 001 mg to about 0 . 8 mg , alternatively about 0 . 001 mg to about 0 . 7 mg , alternatively about 0 . 001 mg to about 0 . 6 mg . methods of administering a topical analgesic containing a neo - tryptophan - containing neurotensin analog are also described . the topical analgesic can be administered in a patch , gel , lotion , spray , or mist .